The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man.
Open Access
- 1 January 1978
- journal article
- Published by Wiley
- Vol. 5 (1) , 7-11
- https://doi.org/10.1111/j.1365-2125.1978.tb01591.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cardiovascular effects of a new inotropic drug in dog and normal manClinical Pharmacology & Therapeutics, 1976
- Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements.BMJ, 1975
- Dopamine — Clinical Uses of an Endogenous CatecholamineNew England Journal of Medicine, 1974
- CLINICAL CARDIOVASCULAR PHARMACOLOGY OF DOBUTAMINE A SELECTIVE INOTROPIC CATECHOLAMINEThe Lancet, 1974
- Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease.Heart, 1973
- Acute Hemodynamic Effects of Dopamine in Patients with ShockCirculation, 1971
- True isovolumic contraction timeThe American Journal of Cardiology, 1970
- Effect of Digitalis on Systolic Time Intervals in Heart FailureThe Lancet Healthy Longevity, 1970
- Activation of Adenyl Cyclase by Glucagon in Cat and Human HeartCirculation Research, 1969
- Effects of Adrenergic Receptor Activation and Blockade on the Systolic Preejection Period, Heart Rate, and Arterial Pressure in ManJournal of Clinical Investigation, 1967